Page 11234..1020..»

Houston Solar Car featured in IMAX film, Smithsonian – Northeast Mississippi Daily Journal

Posted: February 24, 2017 at 5:44 pm

Floyd Ingram | Buy at photos.chickasawjournal.com Dream Big, featuring Sundancer, debuted at the Tennessee Aquarium in Chattanooga last week with members of the Houston Solar Car team in attendance. Members are Kailey Stevens, from left, Malik Lawrence, James Ingram, Micah Simmons and Greg Hollingsworth.

By Floyd Ingram

Chickasaw Journal

HOUSTON Sundancer was featured in a documentary film that debuted last week at cinemas around the country, and part of that rollout saw it put on display at the Smithsonian Institute in Washington, D.C.

Houston Solar Car team members also headed out to Washington, Chattanooga, Birmingham and Huntsville Alabama, for the premier of Dream Big, a film aimed at growing the next generation of engineers to serve both the United States and the world.

I was inspired by a fifth grade science teacher in a day and age when girls were not encouraged to go into engineering, said Mary Beth Hudson, site manager of Wacker Polysilicon in Charleston, Tennessee. Engineers will solve the problems we face in the future. I think it is obvious to us all, we need more engineers.

Hudson spoke before the premier of Dream Big at the Tennessee Aquarium in Chattanooga last Friday. Hudson, who runs the $2.5 billion plant that makes a key material used in solar cells, said her passion is getting kids excited about careers in engineering.

I am so impressed with what your solar car team has done, Hudson said. The next generation of engineers are all around us. We need to spot them, educate them and put them in companies that are working on solutions to solve the worlds problems.

The Houston Solar Car team was featured for about six minutes in the 45-minute documentary. The segment told of a small high school in Mississippi that fielded a solar car that went to Australia in 2015 and raced the most miles under solar power in the 2,000 mile World Solar Car Challenge across the Australian Outback.

Sundancer finished the race with 2,795 solar car kilometers, or 1,736 miles, racing all but 227 kilometers of the 3,022 kilometer race from Darwin to Adelaide.

The film premiered in giant-screen theaters during Engineers Week, Feb. 17-25, around the country.

Sundancer, right, and the University of Michigan solar car were on display at the Smithsonian Institute in Washington, D.C. (Courtesy)

Houston Career and Technology Education Center solar car sponsor and chaperons carried students Hunter Moore and Andrew Mitchell along with Sundancer to Washington for the premier there.

Narrated by Academy Award winner Jeff Bridges, Dream Big: Engineering Our World is a first of its kind film for IMAX and giant screen theaters that seeks to transform how we think about engineering.

The film urges teachers, schools and companies to answer the call of the STEM (Science, Technology, Engineering, Math) initiative which offers a fresh perspective on engineering and aims to inspire kids of diverse backgrounds to become the innovators, educators and leaders who will improve the lives of people across our entire planet throughout the 21st Century.

STEM was implemented in the Houston School District last year.

For more information about Dream Big, go to http://www.dreambigfilm.com. Click the sneak peak trailer to view a 2-minute video. Click the icon marked Press to see photos of the Houston Solar Car team in Australia.

Read the original here:
Houston Solar Car featured in IMAX film, Smithsonian – Northeast Mississippi Daily Journal

Posted in Alabama Stem Cells | Comments Off on Houston Solar Car featured in IMAX film, Smithsonian – Northeast Mississippi Daily Journal

Nasdaq Slips as Biotechnology Shares Decline – Wall Street Journal (subscription)

Posted: at 5:43 pm


Wall Street Journal (subscription)
Nasdaq Slips as Biotechnology Shares Decline
Wall Street Journal (subscription)
Declines in biotechnology shares dragged down the Nasdaq Composite, pressuring an index that has soared so far this year. The Nasdaq fell 0.4% Thursday but is up more than 8% in 2017, outperforming both the Dow Jones Industrial Average and the S&P …

and more »

The rest is here:
Nasdaq Slips as Biotechnology Shares Decline – Wall Street Journal (subscription)

Posted in Biotechnology | Comments Off on Nasdaq Slips as Biotechnology Shares Decline – Wall Street Journal (subscription)

Trump’s China ambassador vows to make beef trade and biotechnology priorities – Agri-Pulse

Posted: at 5:43 pm

WASHINGTON, Feb. 23, 2017 Iowa Gov. Terry Branstad, President Trumps choice to be the next U.S. ambassador to China, said today that if confirmed he will make it a priority to get China to lift its ban on U.S. beef and reform its biotechnology approval process.

Branstad spoke at USDAs annual Agricultural Outlook Forum before a scheduled meeting at the Chinese embassy in Washington,

We soon hope to reopen the market for American beef, Branstad said. I want to serve it at the (U.S.) embassy and I certainly want to do what I can to convince the Chinese leadership to do that sooner than later.

It was in September last year that China announced it was going to lift its 14-year-old ban on U.S. beef, but there have been no signs since then that the country was actually following through with that promise.

China was just one of many countries that banned U.S. beef in 2003 after theU.S. discovered its first case of bovine spongiform encephalopathy (BSE).Since then most countries have lifted those bans, and in 2013 the World Organization for Animal Health (OIE) announced that it was placing the U.S. into the negligible, or lowest risk category, for BSE, commonly known as mad cow disease.. Previously the U.S. fell into the higher controlled risk category.

Mad cow disease is long since gone in this country, Branstad said. Theres no reason why the Chinese should continue to restrict American beef. Thats one of the things high on my priority list.

Another thing high on his priority list is persuading China to reform its biotechnology approval process. The Obama administration tried for years to get China to begin the approval process of new seed traits at the same time as regulators in the U.S. or other countries begin. But little progress has been made.

China, to the growing frustration of U.S. farm groups and biotech seed companies, continues to refuse to begin its approval process until new traits have already been approved in another country first. That can add years to the time that it takes for seed companies to get their products on the market.

Furthermore, Branstad said another priority wouldbe to persuadethe Chinese to remove stiff import duties on U.S. distillers dried grains with solubles (DDGS).

It was just last month that Chinas Commerce Ministry slapped new duties and taxes on DDGS that total roughly 90 percent of the price of the commodity, a byproduct of ethanol production and a popular livestock feed ingredient.

U.S. Grains Council President Tom Sleight says the barriers are high enough to virtually halt U.S. exports to China.

China bought 6.3 million tons of DDGS in 2015, valued at about $1.6 billion, according to U.S. Grains Council officials. That was up from 4.3 million tons, valued at $1.25 billion,in 2014.

Branstad told Agri-Pulse that he expects to succeed where others have failed in China because of his strong personal relationships with Chinese President Xi Jinping and other high-ranking officials.

I have the advantage of being an old friend of President Xi, he said.His very first trip to America was to Iowa. He led a corn processing delegation that came to Iowa in 1985.

The two have stayed in contact since then, Branstad said. We have a longstanding personal relationship and thats really important in their culture. I think thats why President Trump chose me.

Branstad also stressed today that the U.S. and China are already major trading partners and he hopes to expand that relationship.

IncreasingChinas demand for U.S. farm commodities took up a significant part of USDA Chief Economist Robert Johansson’s presentation today at the Outlook Forum.

Are you tracking trade issues? Follow Agri-Pulse for more in-depth coverage. Sign up for a four-week free trial now.

China is the largest destination for U.S. agricultural exports and the country’s demand continues togrow for American soybeans, cotton, wheat and other commodities, Johansson said.

In (fiscal year) 2017 U.S. exports to China are projected at $22.3 billion, up more than $3 billion from 2016 and making it the top export market for U.S. agriculture, Johansson said.

The future is especially bright for Chinese imports of soybeans and cotton, he said, predictingthat China will be buying about 14 million bales of cotton from the U.S. annually 10years from now, a 9.6-million-bale increase from present sales.

I look forward to being an advocate for all agricultural exports in this new role. Im humbled by the prospect that a farm kid from Iowa could be chosen to represent our country in China.

#30

For more news, go to: http://www.Agri-Pulse.com

Read more from the original source:
Trump’s China ambassador vows to make beef trade and biotechnology priorities – Agri-Pulse

Posted in Biotechnology | Comments Off on Trump’s China ambassador vows to make beef trade and biotechnology priorities – Agri-Pulse

Thanks to Stem Cell Therapy, Thinning Hair May Be a Thing of the … – W Magazine

Posted: at 5:41 pm

Call me a creature of habit, or just plain boring, but Ive been wearing my hair long, blonde, straight, and side-parted for more than 15 years. The only thing thats really changed is how much of it I have left. Whether the result of bleach, blowouts, stress, hormones, genetics, or all of the above, Ive been shedding like a cheap angora sweater since the age of 30. And, to make matters worse, the hair I do have is fine, fragile, and flyaway.

It wasnt always so. Flipping through old photo albums, I found evidence not only of my natural color (a long-forgotten brown) but also of the graphic, blunt bob I sported in my early 20s. I had oodles of hair back then and would smooth it to my head with pomade and push it behind my earsmuch like Guido Palau did on some of the models in Pradas spring runway show, I noted smugly.

Efforts in the ensuing years to save my ever-sparser strands have been all but futile. You name it, Ive tried it: platelet-rich plasma (PRP), treatments in which your own blood is spun down to platelets and injected into your scalp; mesotherapy (painful vitamin shots, also in the scalp); oral supplements; acupuncture; massage; herbal remedies; and high-tech hair products. Ive even resorted to wearing a silly-looking helmet that bathed my head in low-level laser light and was said to stimulate failing follicles. At this point, I would soak my mane in mares milk under the glow of a waxing supermoon if I thought it would help.

Since hair regeneration is one of the cosmetics-research worlds holiest grails (read: potential multibillion-dollar industry), Ive always hoped that a bona fide breakthrough was around the corner, and prayed it would arrive well ahead of my dotage. As it turns out, it might actually be a five-hour flight from New Yorkand around $10,000away.

It was the celebrity hairstylist Sally Hershberger who whispered the name Roberta F. Shapiro into my ear. You have to call her, she said. She is on to something, and it could be big. Shapiro, a well-respected Manhattan pain-management specialist, treats mostly chronic and acute musculoskeletal and myofascial conditions, like disc disease and degeneration, pinched nerves, meniscal tears, and postLyme disease pain syndromes. Her patient list reads like a whos who of the citys power (and pain-afflicted) elite, and her practice is so busy, she could barely find time to speak with me. According to Shapiro, a possible cure for hair loss was never on her agenda.

But thats exactly what she thinks she may have stumbled upon in the course of her work with stem cell therapy. About eight years ago, she started noticing a commonality among many of her patientsevidence of autoimmune disease with inflammatory components. Frustrated that she was merely palliating their discomfort and not addressing the underlying problems, Shapiro began to look beyond traditional treatments and drug protocols to the potential healing and regenerative benefits of stem cellsspecifically, umbilical cordderived mesenchymal stem cells, which, despite being different from the controversial embryonic stem cells, are used in the U.S. only for research purposes. After extensive vetting, she began bringing patients to the Stem Cell Institute, in Panama City, Panama, which she considers the most sophisticated, safe, and aboveboard facility of its kind. Its not a spa, or a feel-good, instant-fix kind of place, nor is it one of those bogus medical-tourism spots, she says. Lori Kanter Tritsch, a 55-year-old New York architect (and the longtime partner of Este Lauder Executive Chairman William Lauder) is a believer. She accompanied Shapiro to Panama for relief from what had become debilitating neck pain caused by disc bulges and stenosis from arthritis, and agreed to participate in this story only because she believes in the importance of a wider conversation about stem cells. If it works for hair rejuvenation, or other cosmetic purposes, great, but that was not at all my primary goal in having the treatment, Kanter Tritsch said.

While at the Stem Cell Institute, Kanter Tritsch had around 100 million stem cells administered intravenously (a five-minute process) and six intramuscular injections of umbilical cord stem cellderived growth factor (not to be confused with growth hormone, which has been linked to cancer). In the next three months, she experienced increased mobility in her neck, was able to walk better, and could sleep through the night. She also lost a substantial amount of weight (possibly due to the anti-inflammatory effect of the stem cells), and her skin looked great. Not to mention, her previously thinning hair nearly doubled in volume.

As Shapiro explains it, the process of hair loss is twofold. The first factor is decreased blood supply to hair follicles, or ischemia, which causes a slow decrease in their function. This can come from aging, genetics, or autoimmune disease. The second is inflammation. One of the reasons I think mesenchymal stem cells are working to regenerate hair is that stem cell infiltration causes angiogenesis, which is a fancy name for regrowing blood vessels, or in this case, revascularizing the hair follicles, Shapiro notes. Beyond that, she says, the cells have a very strong anti-inflammatory effect.

For clinical studies shes conducting in Panama, Shapiro will employ her proprietary technique of microfracturing, or injecting the stem cells directly into the scalp. She thinks this unique delivery method will set her procedure apart. But, she cautions, this is a growing science, and we are only at the very beginning. PRP is like bathwater compared with amniotic- or placenta-derived growth factor, or better yet, umbilical cordderived stem cells.

Realizing that not everyone has the money or inclination to fly to Panama for a treatment that might not live up to their expectations, Hershberger and Shapiro are in the process of developing Platinum Clinical, a line of hair products containing growth factor harvested from amniotic fluid and placenta. (Shapiro stresses that these are donated remnants of a live birth that would otherwise be discarded.) The products will be available later this year at Hershbergers salons.

With follicular salvation potentially within reach, I wondered if it might be time to revisit the blunt bob of my youth. I call Palau, and inquire about that sleek 1920s do he created for Prada. Fine hair can actually work better for a style like this, he says. In fact, designers often prefer models with fine hair, so the hairstyle doesnt overpower the clothing. Then he confides, Sometimes, if a girl has too much hair, we secretly braid it away. Say what? I know, its the exact opposite of what women want in the real world. But models are starting to realize that fine hair can be an asset. Look, at some point you have to embrace what you have and work with it. Wise words, perhaps, and proof that, like pretty much everything else, thick hair is wasted on the young.

From the Minimalist to the Bold, the 5 Best Hair Trends of New York Fashion Week

Watch W’s most popular videos here:

Here is the original post:
Thanks to Stem Cell Therapy, Thinning Hair May Be a Thing of the … – W Magazine

Posted in Cell Therapy | Comments Off on Thanks to Stem Cell Therapy, Thinning Hair May Be a Thing of the … – W Magazine

HealthWatch: Stem Cell Therapy for Osteoarthritis – WeAreGreenBay.com

Posted: at 5:41 pm

CHICAGO. (Ivanhoe Newswire) — Osteoarthritis is the most common form of arthritis in the U.S., affecting nearly 27 million adults. It is currently an incurable disease in which the joints deteriorate. Now, a therapy that has been used in eye surgery and to heal the skin of burn victims is being used for the first time in knees. This new form of treatment involves stem cells from amniotic fluid.

As a professional photographer, climbing up step ladders and walking down stairs are part of the daily grind for 65-year-old Linda Schwartz.

“There’s constant activity; you’re moving the whole time, really,” Schwartz told Ivanhoe.

But the pain of osteoarthritis in both of her knees was making all that activity a little harder.

Schwartz detailed, “I tried cortisone shots. I had something called Euflexxa. I was sent to physical therapy twice. I mean, I did try acupuncture in my knees. But it didn’t really seem to make a difference.”

Adam Yanke, M.D., an orthopedic surgeon at Rush University Medical Center in Chicago, explained, “It’s like the rubber on the tire. So as you start to lose the rubber in your tire and the rim hits the road, that’s what happens when you have bone on bone arthritis and you’ve lost all the cartilage in your knee.”

Dr. Yanke enrolled Schwartz in an experimental new therapy that involved injecting amniotic fluid that contained stem cells donated by healthy mothers into the knees of osteoarthritis patients.

“Between the two of those they’re a potent anti-inflammatory and they also have growth factors that help promote healing or healthy growth of tissue,” said Dr. Yanke.

It was by far the most effective pain treatment that Schwartz has tried. Unlike cortisone shots, there are no side effects. The pain relief has so far lasted up to a year.

“It was a very gradual feeling of it’s a little bit better, it’s a little bit better, and then realizing, wow, it’s really pretty good,” said Schwartz.

The one drawback is this therapy is not for patients whose arthritis is so bad it requires knee replacement surgery. Even though it’s still in the experimental stage, Dr. Yanke offers the stem cell treatment to his patients. But at a cost of $2,200 a shot, it is not yet covered by insurance.

Contributors to this news report include: Cyndy McGrath, Supervising Producer; Jessica Sanchez, Field Producer; Milvionne Chery, Assistant Producer; Roque Correa, Editor.

MEDICAL BREAKTHROUGHS

RESEARCH SUMMARY

TOPIC: Stem Cell Therapy for Osteoarthritis

REPORT: MB #4213

BACKGROUND: Osteoarthritis, also known as degenerative joint disease or degenerative arthritis, is the most chronic condition in the joints, affecting 27 million Americans. This disease is an incurable one in which the tissue and bone in the joints deteriorate. Because the cartilage is a cushion between the bones, when this is lost a person can experience considerable pain, swelling and problems when moving the joint. This condition can affect people of any age, but it is more common in people over the age of 65. Some common risk factors include:

* Age

* Obesity

* Previous joint injury

* Overuse of the joint

* Weak thigh muscles

* Genetics

(Source: http://www.arthritis.org/about-arthritis/types/osteoarthritis/what-is-osteoarthritis.php)

TREATMENTS: Although there is no cure for osteoarthritis, there are several treatments that exist to treat it. Each treatment depends on the patient and the severity of the disease, but all focus on managing pain, stiffness and swelling; as well as joint mobility and flexibility. Some of these treatments are:

* Medications, like analgesics, nonsteroidal anti-inflammatory drugs, pills, cream and lotions

* Physical and occupational therapies

* Surgery

* Natural and alternative therapies like nutritional supplements, acupuncture, massages, physical activities, and weight management

(Source: http://www.arthritis.org/about-arthritis/types/osteoarthritis/treatment.php)

STEM CELL THERAPY: Stem cell therapy consists of a membrane product that also has amniotic fluid in it. They are usually used in eye surgery and to heal the skin of burned victims but now they’re being used to treat osteoarthritis in an experimental therapy. The main goal of the trial is to demonstrate this is an adequate therapy for relieving inflammation in the joints. The therapy involves injecting amniotic fluid that contains stem cells donated by healthy mother into the knees of patients. Dr. Adam Yanke says it’s too soon to tell if the stem cell therapy will actually help with growing back healthy tissue in order to avoid surgery, or if it will simply delay the process. Furthermore, the therapy can’t be given to patients suffering from chronic arthritis and are in need of knee replacement surgery. Nevertheless, the treatment helps with pain relief, movement and there are no reported side effects.

(Source: Adam Yanke)

FOR MORE INFORMATION ON THIS REPORT, PLEASE CONTACT:

Deb Song

Media Relations

Deb_song@rush.edu

If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Marjorie Bekaert Thomas at mthomas@ivanhoe.com

Original post:
HealthWatch: Stem Cell Therapy for Osteoarthritis – WeAreGreenBay.com

Posted in Cell Therapy | Comments Off on HealthWatch: Stem Cell Therapy for Osteoarthritis – WeAreGreenBay.com

TxCell raises cash for first-in-man CAR-Treg cell therapy study – BioPharma-Reporter.com

Posted: at 5:41 pm

TxCell has raised 11m ($11.6m) through a share issue which it will use to fund first-in-man study of one of its cell therapy candidates.

The shares were bought by new backers like Auriga Ventures II and ING Luxembourg a S.A. as well as existing TxCell investors Innobio FCPR andBpifrance Participation Large Venture.

CEO Stephane Boissel told us “TxCell hasrealigned its strategy, being the first to move into the Car-Treg field in auto-immune diseases. Thefinance will help TxCell to get through to a first IND approval to initiate a first-in-man study with a CAR-Treg candidate, which is expected by the end of 2018.

He added that: “This study will be a world first. It most likely would be in solid organ transplantation, to treat or prevent chronic rejection.

TxCell has four CAR-Treg candidates in his pipeline. Three are for the treatment of diseases, specifically lupus nephritis, bullous pemphigoid and multiple sclerosis. The fourth is designed to prevent graft-versus-host disease after transplantation.

All four were developed using the firms ENTrIA platform which uses CARs to direct antigen-specific regulatory cells (Ag-Tregs) to target autoimmune inflammatory diseases.

All four are listed as being in early phase development on TxCells website.

Two of the therapies, the GvHD treatment ENTX#SOT and the lupus candidate ENTX#LN are the subject of preclinical research accords signed last year.

ENTX#BP, which is being developed as a treatment for the rare skin blistering disease bullous pemphigoid, is also the focus of a preclinical research partnership.

However, when TxCell announced the deal with the Lubeck Institute of Experimental Dermatology (LIED) in June it said the aim was to conduct non-clinical pharmacology studies with CAR-Treg cells to prepare for a first-in-man study.

Read more from the original source:
TxCell raises cash for first-in-man CAR-Treg cell therapy study – BioPharma-Reporter.com

Posted in Cell Therapy | Comments Off on TxCell raises cash for first-in-man CAR-Treg cell therapy study – BioPharma-Reporter.com

Contemplating stem cell therapy for epilepsy-induced … – Dove Medical Press

Posted: at 5:41 pm

Back to Browse Journals Neuropsychiatric Disease and Treatment Volume 13

Gautam Rao, Sherwin Mashkouri, David Aum, Paul Marcet, Cesar V Borlongan

Department of Neurosurgery and Brain Repair, Center of Excellence for Aging and Brain Repair, University of South Florida Morsani College of Medicine, Tampa, FL, USA

Abstract: Epilepsy is a debilitating disease that impacts millions of people worldwide. While unprovoked seizures characterize its cardinal symptom, an important aspect of epilepsy that remains to be addressed is the neuropsychiatric component. It has been documented for millennia in paintings and literature that those with epilepsy can suffer from bouts of aggression, depression, and other psychiatric ailments. Current treatments for epilepsy include the use of antiepileptic drugs and surgical resection. Antiepileptic drugs reduce the overall firing of the brain to mitigate the rate of seizure occurrence. Surgery aims to remove a portion of the brain that is suspected to be the source of aberrant firing that leads to seizures. Both options treat the seizure-generating neurological aspect of epilepsy, but fail to directly address the neuropsychiatric components. A promising new treatment for epilepsy is the use of stem cells to treat both the biological and psychiatric components. Stem cell therapy has been shown efficacious in treating experimental models of neurological disorders, including Parkinsons disease, and neuropsychiatric diseases, such as depression. Additional research is necessary to see if stem cells can treat both neurological and neuropsychiatric aspects of epilepsy. Currently, there is no animal model that recapitulates all the clinical hallmarks of epilepsy. This could be due to difficulty in characterizing the neuropsychiatric component of the disease. In advancing stem cell therapy for treating epilepsy, experimental testing of the safety and efficacy of allogeneic and autologous transplantation will require the optimization of cell dosage, delivery, and timing of transplantation in a clinically relevant model of epilepsy with both neurological and neuropsychiatric symptoms of the disease as the primary outcome measures.

Keywords: epilepsy, neuropsychiatric, stem cells, autologous

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Go here to see the original:
Contemplating stem cell therapy for epilepsy-induced … – Dove Medical Press

Posted in Cell Therapy | Comments Off on Contemplating stem cell therapy for epilepsy-induced … – Dove Medical Press

Dealing with diabetes distress – Chicago Tribune

Posted: at 5:41 pm

People with diabetes have to think about their condition and make treatment decisions constantly and all that extra work and worry can lead to psychological distress at times.

“Diabetes distress” isn’t the same as depression, diabetes experts note. It’s a condition unique to the 24/7 demands that come with diabetes, particularly for people dependent on insulin.

“The day you develop diabetes, it’s like the universe just handed you a new full-time job that you have to do in addition to whatever else you’re doing. It’s a special job that has a big impact on the rest of your life. There’s no pay and no vacation,” said William Polonsky, president of the Behavioral Diabetes Institute in San Diego.

RELATED: TRENDING LIFE & STYLE NEWS THIS HOUR

Alicia McAuliffe-Fogarty, vice president of lifestyle management at the American Diabetes Association, put it this way: “Diabetes distress is the extra burden that people with diabetes have to carry. They have to do everything that other people do take care of work, family, finances and in addition they have to make sure to check their blood sugar, remember to take their medicine and/or adjust their insulin doses, count carbohydrates when they eat.

“It’s a day-to-day and minute-to-minute burden. It’s doing everything ‘right’ and still seeing your blood sugar levels go up,” she added.

Diabetes distress is a range of different emotional responses that come with dealing with the burdens of caring for diabetes, Polonsky explained.

“It’s being fed up and overwhelmed with the demands and concerns of diabetes. It’s feeling powerless in the face of diabetes. It’s knowing that despite your best actions, sometimes those [insulin] numbers go up and down and it seems beyond your ability to influence. And it can negatively influence one’s quality of life,” he added.

The phenomenon hasn’t been well-studied Polonsky said he and his colleagues are in the middle of a study on diabetes distress that will hopefully answer some questions about the condition that affects an estimated 30 percent of people with diabetes at some point in their lives.

“It’s not everybody, and it’s not all the time, but it’s pretty darn common, and a whole lot more common than depression” among those with diabetes, Polonsky added.

Diabetes distress and other psychological conditions are common enough that the American Diabetes Association added a section to its guidelines, published recently in the journal Diabetes Care, suggesting that providers screen all of their diabetes patients for these mental health concerns.

Juggling job with no breaks

There are two main types of diabetes: Type 1 and Type 2.

People with Type 1 diabetes don’t make enough insulin, a hormone the body needs to use the carbohydrates in food for fuel. Because of this, people with Type 1 rely on insulin injections or insulin delivered through a tiny catheter inserted under the skin and then attached to an insulin pump worn outside the body. People with Type 1 diabetes using shots may need five or six insulin injections daily.

In people with Type 2 diabetes, the body is no longer able to use insulin properly. Most (95 percent) of diabetes cases involve the Type 2 form. Sometimes, people with Type 2 diabetes also need to use insulin injections.

Using insulin is a difficult balancing act too much or too little can cause problems, even life-threatening ones. When blood sugar levels drop too low from too much insulin, people can become disoriented, and if levels drop even further, they may pass out. Blood sugar levels that are too high and left untreated over time can cause complications such as kidney troubles, eye problems and heart disease.

To keep track of blood sugar levels when using insulin, most people rely on glucose meters and a lancing device that pricks the finger to draw out a drop of blood. This may be done as few as 4 times a day, or as many as a dozen or more times daily, depending on how blood sugar levels are fluctuating.

Many factors besides insulin can influence blood sugar levels. Food, alcohol, physical activity, emotions such as stress, and illness all can cause unpredictable changes in blood sugar levels.

Strength in numbers

Both Polonsky and McAuliffe-Fogarty said it’s important to recognize and treat diabetes distress because it can have a negative impact on blood sugar management.

“In some studies, diabetes distress can impact diabetes care more than depression,” McAuliffe-Fogarty said.

Antidepressants aren’t likely to help someone with diabetes distress, according to Polonsky.

McAuliffe-Fogarty suggests checking in with your health care provider so you can go over your current diabetes management regimen. It’s possible that changes in your management might help, she said.

Or, it might help to have a visit with a diabetes educator to go over some of the basics again, she recommended. Many people with Type 1 diabetes are diagnosed as children, and as adults may not realize they’re missing some of the basics of diabetes education.

“Maybe pick one or two things that would make the most impact on your management and focus on those one or two small things, and you’ll likely achieve those goals. Then set one or two more goals and move along like that not everything needs to happen at once,” McAuliffe-Fogarty said.

Both experts agreed that support is an important component of treating diabetes distress. “You don’t want to do diabetes alone. If you have someone who’s rooting for you, that really helps,” Polonsky said.

He said parents or spouses can give a person with diabetes a break by taking over the management of the disease for a little while. It gives them a “diabetes vacation.”

For some, distress can get more serious. McAuliffe-Fogarty said about one in every four or five people with diabetes will experience depression at some point.

She said signs that suggest you need to speak with a mental health professional include: changes in appetite and sleep patterns, having no interest in activities you once enjoyed, social isolation, feeling persistently sad or hopeless, and having a down mood on more days than not.

Read the original here:
Dealing with diabetes distress – Chicago Tribune

Posted in Diabetes | Comments Off on Dealing with diabetes distress – Chicago Tribune

Diabetes grant approved in Richmond County – Ansonrecord

Posted: at 5:41 pm

ROCKINGHAM In North Carolina in 2015, the diabetes mortality rate (number of deaths in a population) was 22.2 per 100,000 while the rate of diabetes prevalence (number diagnosed) was 9.8 percent. The rate of prediabetes prevalence (diagnosed as pre-diabetic) was 5.1 percent.

During the same period, the mortality rate of Richmond County (population approximately 46,600) was 54.8 percent per 100,000, its diabetes prevalence rate was 22.9 percent and its rate of prediabetes prevalence was 6.8 percent.

FirstHealth of the Carolinas will approach these alarming statistics with a program funded by a two-year $263,109 grant to its Community Health Services department from the Kate B. Reynolds Charitable Trust. The funds will address pre-diabetes in both Richmond and Montgomery counties (another community with high diabetes and pre-diabetes rates) by offering glucose screenings in non-traditional locations.

Individuals with a pre-diabetes glucose result will be referred to an evidence-based pre-diabetes education curriculum developed by the Centers for Disease Control and Prevention. A structured lifestyle change program developed specifically to prevent type 2 diabetes, the program is designed for people who have pre-diabetes or are at risk for type 2 diabetes, but have not developed full-blown diabetes.

A trained lifestyle coach will work with participants to help them change certain aspects of their lifestyle, including eating healthier, reducing stress and getting more physical activity. Participants in the program, which will meet one time a week for 16 weeks, bi-monthly for the following two months and then once a month for the rest of the year, also get group support from others who share similar goals and struggles.

We have very strong partners in our 2020 Task Force groups in these two counties, Roxanne Elliott, policy director for FirstHealth Community Health Services, said. Our health programs team will coordinate the pre-diabetes project, and we will work with our partners to help refer into the program and assist with promoting and scheduling the glucose screenings.

The Kate B. Reynolds Charitable Trust was established in 1946 as the legacy of the late Kate Gertrude Bitting Reynolds, who was married to William Neal Reynolds, chairman of R.J. Reynolds Tobacco Company. Its mission is to improve the quality of life and the quality of health for the financially needy of North Carolina.

We are very grateful to the Kate B. Reynolds Charitable Trust for providing the funding that will help us address a health issue of great concern in Richmond County, John Jackson, president of FirstHealth Richmond Memorial Hospital in Rockingham and Sandhills Regional Medical Center in Hamlet, said. Type 2 diabetes affects too many people in our community. We hope this program, which is geared toward people who are at risk for diabetes but have not yet developed the disease, will make an enormous difference in their lives as well as in the health and well-being of the Richmond County community.

For more information about FirstHealths pre-diabetes program, contact Roxanne Elliott, of FirstHealth Community Health Services, at 910-715-3487.

.

Link:
Diabetes grant approved in Richmond County – Ansonrecord

Posted in Diabetes | Comments Off on Diabetes grant approved in Richmond County – Ansonrecord

Diabetes Testing at the Dentist’s Office – New York Times

Posted: at 5:41 pm


New York Times
Diabetes Testing at the Dentist's Office
New York Times
Periodontitis, a chronic gum infection characterized by swollen, tender or receding gums, can be an early warning sign of Type 2 diabetes, and dental offices could be an ideal place to screen for it, said Wijnand J. Teeuw, the first author of a new
Should Dentists Screen for Diabetes?MedPage Today
Periodontitis may be an early sign of type 2 diabetes – Medical News …Medical News Today
BLEEDING GUMS WARNING: Periodontitis could be early sign of DIABETESExpress.co.uk

all 10 news articles »

More:
Diabetes Testing at the Dentist’s Office – New York Times

Posted in Diabetes | Comments Off on Diabetes Testing at the Dentist’s Office – New York Times

Page 11234..1020..»